The DOI matches its Crossref record; 431 of the 431 references it cites were found in a registry or an index.
Business Information
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedChobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
To Err Is Human: Building a Safer Health System
(2000) · National Academies Press eBooks · doi:10.17226/9728 · Cited by 14,044
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Research works printed but not linked: 346
- 2002, Endocr Pract, 5
- 2004, Endocr Pract, 4
- 2005, Endocr Pract, 197
- 2003, Endocr Pract, 237
- 2004, Endocr Pract, 353
- 1993, N Engl J Med, 977
- 2000, Eur Heart J, 733
- 1999, Ann Thorac Surg, 352
- 2003, J Thorac Cardiovasc Surg, 1007
- 2004, Endocr Pract, 21
- 2004, Circulation, 1497
- 1999, Circulation, 2626
- 2001, N Engl J Med, 1359
- 2003, JAMA, 1868
- 2006, N Engl J Med, 449
- 2000, Am J Physiol Gastrointest Liver Physiol, G946
- 2004, Diabetes Technol Ther, 105
- 2000, Diabetes Technol Ther, S35
- 2002, Diabetes Metab Res Rev, S14
- 2006, Diabetes Care, 44
- 2005, Diabetes Care, 337
- 2003, JAMA, 1884
- 2003, Pediatrics, e328
- 2004, J Clin Psychiatry, 4
- 2003, Am J Psychiatry, 284
- 2006, Diabetes Care, S43
- 2006, Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: report of a World Health Organization/International Diabetes Foundation Consultation
- 1998, Diabetes Care, 1246
- 2000, Diabet Med, 376
- 2003, Diabetes Care, 688
- 2001, BMJ, 15
- N Engl J Med., 353, 2643, 10.1056/NEJMoa052187 · DOI · Paper page
- Diabetes Care., 27, 17, 10.2337/diacare.27.1.17 · DOI · Paper page
- Diabetologia., 47, 969
- 1999, Lancet, 611
- 2001, JAMA, 1882
- 2003, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [erratum in JAMA, 178
- 2002, Lancet, 1004
- 1997, Diabetes Care, 537
- 2007, Endocr Rev, 187
- 1998, N Engl J Med, 867
- 1999, Diabetes Care, 33
- J Clin Endocrinol Metab, 86, 280, 10.1210/jcem.86.1.7157 · doi:10.1210/jcem.86.1.7157 · Paper page
- 1997, Diabetes Care, 597
- Int J Obes Relat Metab Disord., 24, S21
- 1998, Acta Diabetol, 34
- 1991, Diabetes Care, 732
- 1995, N Engl J Med, 541
- J Indian Med Assoc., 103, 447
- Exp Clin Endocrinol Diabetes, 104, 25
- Diabetes Care., 28, 1083, 10.2337/diacare.28.5.1083 · DOI · Paper page
- 1993, Ann Intern Med, 169
- 1997, Am J Med, 491
- 1996, Diabetes Care, 64
- 1993, Diabetes Care, 621
- 1993, Diabetes Nutr Metab, 147
- 2004, Diabetes Spectrum, 183
- 1998, Endocr Rev, 477
- 1993, N Engl J Med, 1988
- 1999, Atherosclerosis, 229
- 2003, Diabetes Care, 688
- 2004, Arch Intern Med, 2147
- 2001, J Clin Invest, 635
- 1998, Circulation, 1695
- 1999, J Am Coll Cardiol, 146
- 2002, Diabetes Care, 1439
- 2000, Diabetes Metab Res Rev, 125
- 2001, Diabetes Care, 726
- 1993, N Engl J Med, 977
- 2002, Circulation, 2067
- Diabetes Res Clin Pract., 28, 103, 10.1016/0168-8227(95)01064-K · DOI · Paper page
- 1993, Diabetes, 1683
- 2003, Diabetes Care, 1079
- 1997, Arch Intern Med, 1249
- 2000, Eur J Clin Pharmacol, 399
- 2007, Diabetes Care, 263
- 1995, N Engl J Med, 1237
- 1982, Diabetes Care, 479
- 2001, Am J Med, 1
- 2006, Arch Intern Med, 689
- 2005, Am J Med, 1S
- 2000, Diabetes Care, 682
- 2000, Diabetes Educ, 957
- 2004, Arch Intern Med, 1641
- 2000, J Nurs Scholarsh, 225
- 1997, Diabetes, 1001
- 2000, Am J Physiol Gastrointest Liver Physiol, G946
- 1963, Lancet, 785
- 1996, J Clin Invest, 2859
- 1997, Endocrinol Metab Clin North Am, 511
- 1993, Eur J Clin Pharmacol, 113
- 2000, Diabetes Care, 349
- 2000, Diabetes Care, 202
- 1991, Diabetes Care, 342
- 1996, Diabetes Care, 920
- 1996, N Engl J Med, 574
- 1998, Ann Intern Med, 176
- 1994, N Engl J Med, 1188
- 1998, J Clin Endocrinol Metab, 3169
- Endocr Pract., 7, 222, 10.4158/EP.7.3.222 · doi:10.4158/ep.7.3.222
- 2001, Diabetes, 1021
- Lancet, 368, 1770
- Am J Med., 111, 10
- 1998, Diabetes Metab Rev, S31
- Endocrinology, 143, 3152, 10.1210/endo.143.8.8973 · DOI · Paper page
- Ann Intern Med., 143, 559
- 2004, Am J Physiol Endocrinol Metab, E199
- 2005, Clin Diabetes, 78
- 1999, Diabetes Care, 562
- 2000, Am J Kidney Dis, 646
- 1996, JAMA, 1886
- 1999, N Engl J Med, 677
- Ugeskr Laeger, 163, 5519
- 1998, Lancet, 1755
- 1998, N Engl J Med, 645
- 1998, Diabetes Care, 597
- 1999, Lancet, 611
- 2000, Lancet, 359
- 2002, Lancet, 1004
- 1998, Blood, 3527
- 2002, JAMA, 2570
- 1999, Biochem Biophys Res Commun, 681
- 1996, Hypertension, 120
- 2000, Diabetes, 1939
- Ann Intern Med, 131, 660
- 2005, Am J Hypertens, 935
- 2004, Am J Physiol Heart Circ Physiol, H1597
- 2005, Kidney Int, 799
- 1999, Endocr Pract, 51
- 2004, Ann Intern Med, 614
- 2005, Expert Rev Cardiovasc Ther, 433
- 2005, Arch Intern Med, 430
- Circulation, 110, 763, 10.1161/01.CIR.0000140446.06098.6B · doi:10.1161/01.cir.0000140446.06098.6b
- 1998, Circulation, 2513
- 2000, Atherosclerosis, 483
- 1998, Diabetes Care, 69
- 2005, Diabetologia, 2511
- 2005, Arch Intern Med, 2114
- 1985, Am Heart J, 110
- 1992, J Clin Epidemiol, 1327
- 1994, Stroke, 1157
- 1998, Diabet Med, 308
- 2000, Circulation, 1014
- 1999, Scand Cardiovasc J, 166
- 2003, Am Heart J, 1013
- 1999, Am Heart J, S419
- 2002, Nature, 868
- 2004, J Am Coll Cardiol, 2293
- 2004, Arterioscler Thromb Vasc Biol, 1266
- 2002, Circulation, e138
- 2001, Nature, 813
- N Engl J Med, 337, 356
- 2002, Circulation, 2595
- 1995, JAMA, 1049
- 1992, Nutr Rev, 7
- 2005, Arch Intern Med, 1388
- 2000, N Engl J Med, 1148
- 1993, Ann Intern Med, 956
- 1997, Circulation, 44
- 1999, Arterioscler Thromb Vasc Biol, 1368
- 1989, Nature, 303
- 1993, Science, 1655
- 1994, Clin Investig, 558
- 1998, Atherosclerosis, 203
- 2007, JAMA, 499
- 2001, Circulation, 213
- 1990, N Engl J Med, 1289
- 2000, JAMA, 1263
- 2005, Am J Cardiol, 3D
- 2005, Arch Intern Med, 725
- 1998, Diabetes Care, 796
- 2005, Am J Cardiol, 462
- 2001, N Engl J Med, 1583
- 2005, Am J Cardiol, 14K
- 2004, Curr Med Res Opin, 1437
- Lancet, 2005
- N Engl J Med, 354, 1495
- JAMA, 294, 3092
- 2005, Am J Cardiol, 61F
- Lancet, 368, 1415
- 2004, J Am Coll Nutr, 5
- 1992, Metabolism, 1373
- 1994, JAMA, 1421
- 2003, Endocr Pract, 417
- 2001, Br J Nutr, 1
- 1991, J Nutr, 795
- 2005, Br J Nutr, 1
- 2004, Diabetes Care, 2266
- 2006, Endocr Pract, 61
- 1994, Diabetes Care, 1381
- 2003, JAMA, 1713
- 1994, Diabet Med, 656
- 2005, Diabetes Care, 888
- 2001, N Engl J Med, 3
- Ann Intern Med., 142, 313, 10.1001/archinte.1982.00340150113020 · doi:10.1001/archinte.1982.00340150113020
- N Engl J Med., 346, 393, 10.1056/NEJMoa012512 · DOI · Paper page
- 2002, Am J Kidney Dis, S1
- 2003, Am J Kidney Dis, S1
- 2005, Diabetes Care, 164
- 2004, Diabetes Care, 2540
200 of 346 shown
Cited by
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Self-citationDungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.10001 · Cited by 1,279
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Self-citationBenefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01324-6 · Cited by 1,080
Rodbard, H. W., Jellinger, P. S., Davidson, J. A., Einhorn, D., Garber, A. J., Grunberger, G., Handelsman, Y., Horton, E. S., Lebovitz, H., Levy, P., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.6.540 · Cited by 942
on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group, Russell-Jones, D., Vaag, A., Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., & Simó, R. (2009) · Diabetologia · doi:10.1007/s00125-009-1472-y · Cited by 835
Marre, M., Shaw, J., Brändle, M., Bebakar, W. M. W., Kamaruddin, N. A., Strand, J., Zdravkovic, M., Le Thi, T. D., Colagiuri, S., & on behalf of the LEAD‐1 SU study group (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02666.x · Cited by 820
Sorli, C., Harashima, S.-I., Tsoukas, G. M., Unger, J., Karsbøl, J. D., Hansen, T., & Bain, S. C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30013-x · Cited by 745
Hering, B. J., Clarke, W. R., Bridges, N. D., Eggerman, T. L., Alejandro, R., Bellin, M. D., Chaloner, K., Czarniecki, C. W., Goldstein, J. S., Hunsicker, L. G., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1988 · Cited by 645
Jellinger, P. S., Smith, D. A., Mehta, A. E., Ganda, O., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Endocrine Practice · doi:10.4158/ep09102.ra · Cited by 518
Factors associated with poor glycemic control among patients with type 2 diabetes
Khattab, M., Khader, Y. S., Al-Khawaldeh, A., & Ajlouni, K. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.12.008 · Cited by 507
Lazar, H. L., McDonnell, M., Chipkin, S. R., Furnary, A. P., Engelman, R. M., Sadhu, A. R., Bridges, C. R., Haan, C. K., Svedjeholm, R., Taegtmeyer, H., et al. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.11.011 · Cited by 490
Aroda, V. R., Bain, S. C., Cariou, B., Piletič, M., Rose, L., Axelsen, M., Rowe, E., & DeVries, J. H. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30085-2 · Cited by 464
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429
Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial.
Rodbard, H. W., Lingvay, I., Reed, J., de la Rosa, R., Rose, L., Sugimoto, D., Araki, E., Chu, P.-L., Wijayasinghe, N., & Norwood, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00070 · Cited by 412
“5% (48 mmol/mol) (23) by end of treatment; HbA1c ,7.”
Self-citationBodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
De Berardis, G., Sacco, M., Strippoli, G. F. M., Pellegrini, F., Graziano, G., Tognoni, G., & Nicolucci, A. (2009) · BMJ · doi:10.1136/bmj.b4531 · Cited by 395
Flavonols and cardiovascular disease
Perez-Vizcaino, F., & Duarte, J. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.09.002 · Cited by 393
Mechanick, J. I., Kushner, R. F., Sugerman, H. J., Gonzalez-Campoy, J. M., Collazo-Clavell, M. L., Guven, S., Spitz, A. F., Apovian, C. M., Livingston, E. H., Brolin, R., et al. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.08.009 · Cited by 374
DeFronzo, R. A., Okerson, T., Viswanathan, P., Guan, X., Holcombe, J. H., & MacConell, L. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802418851 · Cited by 373
Glycemic control and complications in type 2 diabetes mellitus
Stolar, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.004 · Cited by 356
Mechanick, J. I., Kushner, R. F., Sugerman, H. J., Gonzalez‐Campoy, J. M., Collazo‐Clavell, M. L., Spitz, A. F., Apovian, C. M., Livingston, E. H., Brolin, R., Sarwer, D. B., et al. (2009) · Obesity · doi:10.1038/oby.2009.28 · Cited by 345
Glycemic Control, Complications, and Death in Older Diabetic Patients
Huang, E. S., Liu, J. Y., Moffet, H. H., John, P. M., & Karter, A. J. (2011) · Diabetes Care · doi:10.2337/dc10-2377 · Cited by 343
Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial
Tay, J., Luscombe-Marsh, N. D., Thompson, C. H., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.112581 · Cited by 341
Diabesity: an overview of a rising epidemic
Farag, Y. M. K., & Gaballa, M. R. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq576 · Cited by 320
Keymeulen, B., Walter, M., Mathieu, C., Kaufman, L., Gorus, F., Hilbrands, R., Vandemeulebroucke, E., Van de Velde, U., Crenier, L., De Block, C., et al. (2010) · Diabetologia · doi:10.1007/s00125-009-1644-9 · Cited by 317
Artificial Neural Network Algorithm for Online Glucose Prediction from Continuous Glucose Monitoring
Pérez-Gandía, C., Facchinetti, A., Sparacino, G., Cobelli, C., Gómez, E. J., Rigla, M., de Leiva, A., & Hernando, M. E. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0076 · Cited by 306
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Jeitler, K., Seitz, M., Horvath, K., Berghold, A., & Siebenhofer, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122.pub2 · Cited by 299
van der Heijden, A. A., Abramoff, M. D., Verbraak, F., van Hecke, M. V., Liem, A., & Nijpels, G. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13613 · Cited by 296
“Screening for DR has proven to be effective in the prevention of blindness, and some national health authorities and most professional organizations have adopted an annual or biennial screening programme which is usually integrated within regular diabetes care (Olafsdottir & Stefansson 2007; Rodbard et al. 2007; Scanl…”
BackgroundJadzinsky, M., Pfützner, A., Paz‐Pacheco, E., Xu, Z., Allen, E., Chen, R., & CV181‐039 Investigators (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01056.x · Cited by 296
Ceriello, A., & Colagiuri, S. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02565.x · Cited by 268
A Very Low-Carbohydrate, Low–Saturated Fat Diet for Type 2 Diabetes Management: A Randomized Trial
Tay, J., Luscombe-Marsh, N. D., Thompson, C. H., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2014) · Diabetes Care · doi:10.2337/dc14-0845 · Cited by 260
Freckmann, G., Schmid, C., Baumstark, A., Pleus, S., Link, M., & Haug, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600510 · Cited by 237
Nauck, M. A., Petrie, J. R., Sesti, G., Mannucci, E., Courrèges, J.-P., Lindegaard, M. L., Jensen, C. B., & Atkin, S. L. (2016) · Diabetes Care · doi:10.2337/dc15-0165 · Cited by 233
Meng, Y., Bai, H., Wang, S., Li, Z., Wang, Q., & Chen, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.006 · Cited by 221
“[3] Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, A.”
BackgroundDoehner, W., Erdmann, E., Cairns, R., Clark, A. L., Dormandy, J. A., Ferrannini, E., & Anker, S. D. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.039 · Cited by 215
Kung, J., & Henry, R. R. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.691963 · Cited by 198
Cefalu, W. T., Leiter, L. A., de Bruin, T. W. A., Gause-Nilsson, I., Sugg, J., & Parikh, S. J. (2015) · Diabetes Care · doi:10.2337/dc14-0315 · Cited by 182
Morrow, D. A., Scirica, B. M., Chaitman, B. R., McGuire, D. K., Murphy, S. A., Karwatowska-Prokopczuk, E., McCabe, C. H., & Braunwald, E. (2009) · Circulation · doi:10.1161/circulationaha.107.763912 · Cited by 170
Abd El Aziz, M. S., Kahle, M., Meier, J. J., & Nauck, M. A. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12804 · Cited by 155
Ferket, B. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.434 · Cited by 134
Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy
Jovanovič, L., Liang, Y., Weng, W., Hamilton, M., Chen, L., & Wintfeld, N. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2656 · Cited by 105
Value of Self-Monitoring Blood Glucose Pattern Analysis in Improving Diabetes Outcomes
Parkin, C. G., & Davidson, J. A. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300314 · Cited by 96
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Axel-Schweitzer, M., Petersen, B., & Wagner, R. S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0073 · Cited by 85
Update on diabetes in the elderly and in nursing home residents
Migdal, A., Yarandi, S. S., Smiley, D., & Umpierrez, G. E. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.02.010 · Cited by 81
Management of Glucocorticoid-Induced Hyperglycemia
Shah, P., Kalra, S., Yadav, Y., Deka, N., Lathia, T., Jacob, J. J., Kota, S. K., Bhattacharya, S., Gadve, S. S., Subramanium, K., et al. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s330253 · Cited by 80
“The committee recommended initiating 10 units of basal human insulin with a daily dose increase of 10% to 20% to blood glucose level; however, some individuals may require up to 40% dose increments, as shown in some studies.(18,26)”
BackgroundMethodPleus, S., Baumstark, A., Jendrike, N., Mende, J., Link, M., Zschornack, E., Haug, C., & Freckmann, G. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001067 · Cited by 63
D'Alessio, D., Häring, H. ‐., Charbonnel, B., de Pablos‐Velasco, P., Candelas, C., Dain, M. ‐., Vincent, M., Pilorget, V., Yki‐Järvinen, H., & on behalf of the EAGLE Investigators (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12406 · Cited by 56
Gutiérrez-Salmeán, G., Ortiz-Vilchis, P., Vacaseydel, C. M., Rubio-Gayosso, I., Meaney, E., Villarreal, F., Ramírez-Sánchez, I., & Ceballos, G. (2014) · Food & Function · doi:10.1039/c3fo60416k · Cited by 51
An overview of management issues in adult patients with type 2 diabetes mellitus
Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500207 · Cited by 50
Hurd, W. W., Abdel-Rahman, M. Y., Ismail, S. A., Abdellah, M. A., Schmotzer, C. L., & Sood, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.07.002 · Cited by 46
Berg, A. H., & Sacks, D. B. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.049205 · Cited by 41
Polonsky, W., Fisher, L., Schikman, C., Hinnen, D., Parkin, C., Jelsovsky, Z., Amstutz, L., Schweitzer, M., & Wagner, R. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-37 · Cited by 30
Beyond Self‐Reports: Changes in Biomarkers as Predictors of Mortality
Glei, D. A., Goldman, N., Rodríguez, G., & Weinstein, M. (2014) · Population and Development Review · doi:10.1111/j.1728-4457.2014.00676.x · Cited by 29
Bulchandani, D., Nachnani, J. S., Herndon, B., Molteni, A., Pathan, M. H., Quinn, T., Hamdan, H. A., Alba, L. M., & Graves, L. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.07.024 · Cited by 27
Hompesch, M., Muchmore, D. B., Morrow, L., Ludington, E., & Vaughn, D. E. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0117 · Cited by 25
Therapeutic inertia in type 2 diabetes: Insights from the PANORAMA study in France
Simon, D. (2012) · Diabetes & Metabolism · doi:10.1016/s1262-3636(12)71534-3 · Cited by 23
Freckmann, G., Baumstark, A., Jendrike, N., Mende, J., Schauer, S., Link, M., Pleus, S., & Haug, C. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820948873 · Cited by 12
Comparison of different models of structured self-monitoring of blood glucose in type 2 diabetes
Li, C.-L., Wu, Y.-C., Kornelius, E., Chen, Y.-J., Lin, Y.-T., Hsiao, H.-W., Peng, C.-H., Yang, Y.-S., & Huang, C.-N. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0082 · Cited by 2
Hissa, M. N. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0180-2 · Cited by 1
Metadata
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 13
- Pages
- 2
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W2007003907
- Cited by
- 699
- References
- 431
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.